Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Uses for humanised mouse models in precision medicine for neurodegenerative disease
R. Nair, Silvia Corrochano, Samanta Gasco, et al.
Mammalian Genome (2019) Vol. 30, Iss. 7-8, pp. 173-191
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Opinion: more mouse models and more translation needed for ALS
Elizabeth Fisher, Linda Greensmith, Andrea Malaspina, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 24
Evolving therapeutic interventions for the management and treatment of Alzheimer’s disease
Faizan Ahmad, Anik Karan, Rashi Sharma, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102229-102229
Closed Access | Times Cited: 16
Consideration of Gut Microbiome in Murine Models of Diseases
Chunye Zhang, Craig L. Franklin, Aaron C. Ericsson
Microorganisms (2021) Vol. 9, Iss. 5, pp. 1062-1062
Open Access | Times Cited: 32
Emerging Human Pluripotent Stem Cell-Based Human–Animal Brain Chimeras for Advancing Disease Modeling and Cell Therapy for Neurological Disorders
Yanru Ji, Jenna Lillie McLean, Ranjie Xu
Neuroscience Bulletin (2024) Vol. 40, Iss. 9, pp. 1315-1332
Closed Access | Times Cited: 4
Neuromuscular disease modeling on a chip
Jeffrey W. Santoso, Megan L. McCain
Disease Models & Mechanisms (2020) Vol. 13, Iss. 7
Open Access | Times Cited: 28
Targeting SPI1 to mitigate amyloid-β pathology in Alzheimer's disease
Jie Shao, Hannah Youngblood, Luodan Yang
Journal of Alzheimer s Disease (2025)
Closed Access
Generation ofC9orf72h370mice, an intron 1 humanisedC9orf72repeat-expansion knock-in model
R. Nair, Mireia Carcolé, David Thompson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Long-Term Engraftment of Cryopreserved Human Neurons for In Vivo Disease Modeling in Neurodegenerative Disease
David J. Marmion, Peter Deng, Benjamin M. Hiller, et al.
Biology (2025) Vol. 14, Iss. 2, pp. 217-217
Open Access
Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders
Pratik Chakraborty, Chiranjib Bhattacharyya, Ranabir Sahu, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105267-105267
Closed Access | Times Cited: 9
Mitochondrial impairment and synaptic dysfunction are associated with neurological defects in iPSCs-derived cortical neurons of MERRF patients
Yuting Wu, Hui-Yi Tay, Jung-Tse Yang, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 8
Dystrophic Muscle Affects Motoneuron Axon Outgrowth and NMJ Assembly
Ersilia Fornetti, Stefano Testa, Francesca De Paolis, et al.
Advanced Materials Technologies (2022) Vol. 7, Iss. 7
Open Access | Times Cited: 12
NMDA Receptors in Neurodevelopmental Disorders: Pathophysiology and Disease Models
Roshan Tumdam, Yara Hussein, Tali Garin-Shkolnik, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12366-12366
Open Access | Times Cited: 2
Generation and analysis of innovative genomically humanized knockin SOD1, TARDBP (TDP-43), and FUS mouse models
Anny Devoy, Georgia Price, Francesca De Giorgio, et al.
iScience (2021) Vol. 24, Iss. 12, pp. 103463-103463
Open Access | Times Cited: 13
CRISPR/Cas9 Technology as a Modern Genetic Manipulation Tool for Recapitulating of Neurodegenerative Disorders in Large Animal Models
Mahdi Barazesh, Shiva Mohammadi, Yadollah Bahrami, et al.
Current Gene Therapy (2020) Vol. 21, Iss. 2, pp. 130-148
Closed Access | Times Cited: 11
Evaluating Translational Methods for Personalized Medicine—A Scoping Review
Vibeke Fosse, Emanuela Oldoni, Chiara Gerardi, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1177-1177
Open Access | Times Cited: 7
CRISPR/Cas9-generated mouse model with humanizing single-base substitution in the Gnao1 for safety studies of RNA therapeutics
Anna V. Polikarpova, Tatiana V. Egorova, Evgenii A. Lunev, et al.
Frontiers in Genome Editing (2023) Vol. 5
Open Access | Times Cited: 3
Tracking human neurologic disease status in mouse brain/plasma using reporter-tagged, EV-associated biomarkers
Katia Maalouf, Christine A. Vaine, Dawn M. Frederick, et al.
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 2206-2219
Open Access | Times Cited: 3
Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease
Hongwei Qin, Lianna Zhou, Faris T. Haque, et al.
Journal of Neurochemistry (2023)
Open Access | Times Cited: 3
Monitoring lipid alterations in Drosophila heads in an amyotrophic lateral sclerosis model with time-of-flight secondary ion mass spectrometry
Minh Uyen Thi Le, Jeong Hyang Park, Jin Gyeong Son, et al.
The Analyst (2023) Vol. 149, Iss. 3, pp. 846-858
Open Access | Times Cited: 3
Intracerebral Transplantation and <em>In Vivo</em> Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain
R. Weber, Chantal Bodenmann, Daniela Uhr, et al.
Journal of Visualized Experiments (2022), Iss. 179
Open Access | Times Cited: 5
Mice as an Experimental Model to Understand the Pathobiology of Diseases
Rishika Jana, Souvik Karmakar, Bishal Hazra, et al.
IntechOpen eBooks (2023)
Open Access | Times Cited: 2
Low-Expressing Synucleinopathy Mouse Models Based on Oligomer-Forming Mutations and C-Terminal Truncation of α-Synuclein
Ana Martinez Hernandez, Ivan Silbern, Insa Geffers, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 5
New developments in pre-clinical models of ALS to guide translation
Lenja De Cock, Valérie Bercier, Ludo Van Den Bosch
International review of neurobiology (2024), pp. 477-524
Closed Access
Preclinical research (on rare diseases): we need to talk about health equity
Andy Greenfield
Mammalian Genome (2024)
Open Access
Recombinant Inbred Mice as Models for Experimental Precision Medicine and Biology
David G. Ashbrook, Lu Lu
IntechOpen eBooks (2021)
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top